Evolus’ injectable neurotoxin, Jeuveau, which was approved in 2019 and rivals AbbVie's major blockbuster Botox, knows exactly what it is. It’s an aesthetic product and that’s all it wants to be: no ...

Crows' feet, frown lines, and forehead creases are all signs of a life full of facial expressions. And while some may be reminders of happy memories, it's also totally fine to want to smooth them away ...

When it comes to a scraped knee, you probably reach for a Band-Aid. Sneeze attack? Kleenex, please! Sometimes a brand is so good, so ubiquitous, that it defines an industry. The same could be said for ...

BALA CYNWYD, Pa. (WPVI) -- Botox has a new competitor in the field of wrinkle relaxers. Jeuveau, which is nicknamed the "NewTox," has arrived in this area, just weeks after getting FDA approval. Like ...

Learn about Botox, Dysport, Xeomin, Jeuveau, and Daxxify including how they improve wrinkles, and how to pick the one for your skin. Neurotoxins are injectable solutions that temporarily block the ...

Furthermore, some providers seem not only willing, but downright enthusiastic to provide what is classified as “preventative ...

Evolus is shaking up promotion of its Botox rival. The old campaign was supporting above-market growth of wrinkle-busting product Jeuveau, but Evolus wants more, leading it to launch new branding ...

Evolus is staking a position as a hybrid biopharma/beauty company. Jeuveau is Botox with improved cost structure. We expect Jeuveau to capture second-place in injectable aesthetics market in 2020.

Evolus, Inc., a pharmaceutical company specializing in aesthetic products, faces significant challenges with its lead product Jeuveau, a treatment for frown lines. Jeuveau's undifferentiated clinical ...

Ten years from now, eliminating frown lines and other wrinkles with injectable neurotoxins will be as commonplace as any other beauty treatment at the salon, according to executives at Newport ...

This small-cap stock is going after a billion-dollar market. Jeuveau is an injectable serum containing the botulinum toxin type A compound, the same active ingredient that's in Botox and other facial ...

Please provide your email address to receive an email when new articles are posted on . New phase 2 results showed 40 units of Jeuveau sustained improvements in glabellar lines up to 6 months. Adverse ...